MedPath

Betamethasone

Generic Name
Betamethasone
Brand Names
Betaderm, Betaloan Suik, Beteflam, Celestoderm, Celestone Soluspan, Dermacinrx Therazole Pak, Diprolene, Diprosalic, Diprosone, Dovobet, Enstilar, Fucibet, Lotriderm, Lotrisone, Luxiq, Marbeta, Rivasone, Rolene, Rosone, Sernivo, Taclonex, Valisone-G, Wynzora
Drug Type
Small Molecule
Chemical Formula
C22H29FO5
CAS Number
378-44-9
Unique Ingredient Identifier
9842X06Q6M

Overview

Betamethasone is a long-acting corticosteroid with immunosuppressive and antiinflammatory properties. It can be used topically to manage inflammatory skin conditions such as eczema, and parenterally to manage several disease states including autoimmune disorders. Betamethasone has potent glucocorticoid activity and negligible mineralocorticoid activity.

Background

Betamethasone is a long-acting corticosteroid with immunosuppressive and antiinflammatory properties. It can be used topically to manage inflammatory skin conditions such as eczema, and parenterally to manage several disease states including autoimmune disorders. Betamethasone has potent glucocorticoid activity and negligible mineralocorticoid activity.

Indication

As a member of the corticosteroid family, betamethasone is indicated for the treatment of several inflammatory conditions. As topical monotherapy, betamethasone is indicated to relieve pruritic and inflammatory symptoms of corticosteroid-responsive-dermatoses. Betamethasone can be used topically in combination with a vitamin D analog such as calcipotriene to treat plaque psoriasis. The corticosteroid is also available as an injectable suspension and can be used to manage a range of inflammatory conditions including endocrine disorders, gastrointestinal disorders, and rheumatic disorders among other conditions.

Associated Conditions

  • Acute Gouty Arthritis
  • Adrenocortical Insufficiency
  • Alopecia Areata (AA)
  • Ankylosing Spondylitis (AS)
  • Atopic Dermatitis
  • Berylliosis
  • Blepharitis allergic
  • Blepharoconjunctivitis
  • Bullous dermatitis herpetiformis
  • Bursitis
  • Congenital Adrenal Hyperplasia (CAH)
  • Congenital Hypoplastic Anemia
  • Conjunctivitis
  • Dermatomyositis (DM)
  • Dermatosis
  • Discoid Lupus Erythematosus (DLE)
  • Edema of the cerebrum
  • Epicondylitis
  • Episcleritis
  • External ear inflammation
  • Eye allergy
  • Hypercalcemia of Malignancy
  • Inflammatory Reaction of the ear
  • Iridocyclitis
  • Iritis
  • Itching caused by Allergies
  • Keloids Scars
  • Keratitis
  • Keratitis interstitial
  • Keratoconjunctivitis
  • Leukemias
  • Lichen Planus (LP)
  • Lichen simplex chronicus
  • Lupus Erythematosus
  • Lymphoma
  • Multiple sclerosis exacerbation
  • Mycosis Fungoides (MF)
  • Necrobiosis lipoidica diabeticorum
  • Nephrotic Syndrome
  • Ocular Inflammation
  • Ocular injuries
  • Ophthalmia, Sympathetic
  • Pemphigus
  • Plaque psoriasis of the body
  • Plaque psoriasis of the scalp
  • Polymyositis
  • Post Surgical Ocular Inflammation
  • Pruritus
  • Psoriasis
  • Psoriasis Vulgaris (Plaque Psoriasis)
  • Psoriatic Arthritis
  • Psoriatic plaque
  • Pulmonary Tuberculosis (TB)
  • Pure Red Cell Aplasia
  • Regional Enteritis
  • Rheumatoid Arthritis
  • Rheumatoid Arthritis, Juvenile
  • Scleritis
  • Secondary thrombocytopenia
  • Severe Asthma
  • Severe Atopic Dermatitis
  • Skin Infections
  • Stevens-Johnson Syndrome
  • Systemic Lupus Erythematosus
  • Temporal Arteritis
  • Trichinosis
  • Tuberculous Meningitis
  • Ulcerative Colitis
  • Uveitis
  • Verrucous Lichen Planus (LP)
  • Acquired immune hemolytic anemia
  • Acute nonspecific tenosynovitis
  • Acute rheumatic carditis
  • Bacterial blepharitis
  • Corticosteroid-responsive dermatoses
  • Eczematous rash
  • Exfoliative erythroderma
  • Granuloma annulare lesions
  • Idiopathic eosinophilic pneumonias
  • Non-suppurative Thyroiditis
  • Ocular bacterial infections
  • Severe Allergic rhinitis
  • Severe Contact dermatitis
  • Severe Serum sickness
  • Severe Transfusion Reactions
  • Severe drug hypersensitivity reactions
  • Superficial ocular infections
  • Symptomatic Sarcoidosis
  • Synovitis of osteoarthritis

FDA Approved Products

Clotrimazole and Betamethasone Dipropionate
Manufacturer:A-S Medication Solutions
Route:TOPICAL
Strength:0.5 mg in 1 g
Approved: 2016/07/20
NDC:50090-1558
BETAMETHASONE DIPROPIONATE 0.05% / NIACINAMIDE 4%
Manufacturer:Sincerus Florida, LLC
Route:TOPICAL
Strength:0.05 g in 100 g
Approved: 2019/05/20
NDC:72934-2026
Calcipotriene and Betamethasone Dipropionate
Manufacturer:Prasco Laboratories
Route:TOPICAL
Strength:0.5 mg in 1 g
Approved: 2022/12/12
NDC:66993-938
Betamethasone Dipropionate
Manufacturer:Proficient Rx LP
Route:TOPICAL
Strength:0.5 mg in 1 g
Approved: 2021/01/01
NDC:63187-286
Betamethasone Dipropionate
Manufacturer:E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.
Route:TOPICAL
Strength:0.5 mg in 1 g
Approved: 2016/05/16
NDC:0168-0265

Singapore Approved Products

FUCICORT CREAM
Manufacturer:LEO Pharma A/S, LEO LABORATORIES LIMITED
Form:CREAM
Strength:1 mg/g
Online:Yes
Approved: 1988/05/03
Approval:SIN00723P
BEPROSALIC Lotion
Manufacturer:HOE Pharmaceuticals Sdn. Bhd.
Form:LOTION
Strength:0.064% w/v
Online:Yes
Approved: 2007/07/16
Approval:SIN13316P
SW BETAMETHASONE CREAM 0.1% w/w
Manufacturer:SUNWARD PHARMACEUTICAL PRIVATE LIMITED, SUNWARD PHARMACEUTICAL SDN BHD
Form:CREAM
Strength:0.1% w/w
Online:Yes
Approved: 1990/02/13
Approval:SIN03867P
NEODERM CREAM
Manufacturer:TAI GUK PHARM IND CO LTD
Form:CREAM
Strength:0.5 mg/g
Online:Yes
Approved: 1998/11/23
Approval:SIN10451P
Beprogel Topical Solution 0.05% w/v
Manufacturer:HOE PHARMACEUTICALS SDN BHD
Form:SOLUTION
Strength:0.05 %w/v
Online:Yes
Approved: 1998/10/10
Approval:SIN10242P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath